Dysregulated STAT3 signaling and T cell immunometabolic dysfunction define a targetable, high mortality subphenotype of critically ill children

Sepsis is the leading cause of death of hospitalized children worldwide. Despite the established link between immune dysregulation and mortality in pediatric sepsis, it remains unclear which host immune factors contribute causally to adverse sepsis outcomes. Identifying modifiable pathobiology is an essential first step to successful translation of biologic insights into precision therapeutics. We designed a prospective, longitudinal cohort study of 88 critically ill pediatric patients with multiple organ dysfunction syndrome (MODS), including patients with and without sepsis, to define subphenotypes associated with targetable mechanisms of immune dysregulation. We first assessed plasma proteomic profiles and identified shared features of immune dysregulation in MODS patients with and without sepsis. We then employed consensus clustering to define three subphenotypes based on protein expression at disease onset and identified a strong association between subphenotype and clinical outcome. We next identified differences in immune cell frequency and activation state by MODS subphenotype and determined the association between hyperinflammatory pathway activation and cellular immunophenotype. Using single cell transcriptomics, we demonstrated STAT3 hyperactivation in lymphocytes from the sickest MODS subgroup and then identified an association between STAT3 hyperactivation and T cell immunometabolic dysregulation. Finally, we compared proteomics findings between patients with MODS and patients with inborn errors of immunity that amplify cytokine signaling pathways to further assess the impact of STAT3 hyperactivation in the most severe patients with MODS. Overall, these results identify a potentially pathologic and targetable role for STAT3 hyperactivation in a subset of pediatric patients with MODS who have high severity of illness and poor prognosis.

[1]  T. Sweeney,et al.  Monocyte state 1 (MS1) cells in critically ill patients with sepsis or non-infectious conditions: association with disease course and host response , 2024, Critical care.

[2]  Nuala J Meyer,et al.  Charting a course for precision therapy trials in sepsis. , 2024, The Lancet. Respiratory medicine.

[3]  R. Lodha,et al.  International Consensus Criteria for Pediatric Sepsis and Septic Shock. , 2024, JAMA.

[4]  M. Churpek,et al.  Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. , 2023, The Lancet. Respiratory medicine.

[5]  J. Todd,et al.  Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis , 2023, Nature Immunology.

[6]  N. Meyer,et al.  Interrogating the sepsis host immune response using cytomics , 2023, Critical Care.

[7]  E. Wherry,et al.  Impaired Lymphocyte Responses in Pediatric Sepsis Vary by Pathogen Type and are Associated with Features of Immunometabolic Dysregulation , 2022, Shock.

[8]  M. Singer,et al.  Redefining critical illness , 2022, Nature Medicine.

[9]  J. Casanova,et al.  Diagnosis of APS-1 in Two Siblings Following Life-Threatening COVID-19 Pneumonia , 2022, Journal of Clinical Immunology.

[10]  J. Soar,et al.  An immune dysfunction score for stratification of patients with acute infection based on whole blood gene expression , 2022, Science Translational Medicine.

[11]  K. C. Morris,et al.  Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis , 2022, medRxiv.

[12]  Paul J. Hoffman,et al.  Dictionary learning for integrative, multimodal and scalable single-cell analysis , 2022, bioRxiv.

[13]  S. de Bono,et al.  Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial , 2022, The Lancet Respiratory Medicine.

[14]  J. Casanova,et al.  Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome , 2022, Journal of Clinical Immunology.

[15]  J. Carcillo,et al.  Scoring Systems for Organ Dysfunction and Multiple Organ Dysfunction: The PODIUM Consensus Conference. , 2022, Pediatrics.

[16]  M. Spaeder,et al.  Patterns of Organ Dysfunction in Critically Ill Children Based on PODIUM Criteria. , 2022, Pediatrics.

[17]  J. Carcillo,et al.  Refining the Pediatric Multiple Organ Dysfunction Syndrome. , 2022, Pediatrics.

[18]  D. Teachey,et al.  Temperature Trajectory Sub-phenotypes and the Immuno-Inflammatory Response in Pediatric Sepsis , 2021, Shock.

[19]  Xiaoying Hu,et al.  The JAK/STAT signaling pathway: from bench to clinic , 2021, Signal Transduction and Targeted Therapy.

[20]  A. Hingorani,et al.  Synergistic insights into human health from aptamer- and antibody-based proteomic profiling , 2021, Nature Communications.

[21]  I. Grundberg,et al.  Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis , 2021, Molecular & cellular proteomics : MCP.

[22]  E. Wherry,et al.  Impaired Lymphocyte Responses in Pediatric Sepsis Vary by Pathogen Type , 2021, medRxiv.

[23]  Brenda J. Crowe,et al.  Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial , 2021, The Lancet Respiratory Medicine.

[24]  D. Quirk,et al.  Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia , 2021, The New England journal of medicine.

[25]  P. Khatri,et al.  Gene Expression–Based Diagnosis of Infections in Critically Ill Patients—Prospective Validation of the SepsisMetaScore in a Longitudinal Severe Trauma Cohort , 2021, Critical care medicine.

[26]  Santiago J. Carmona,et al.  UCell: Robust and scalable single-cell gene signature scoring , 2021, bioRxiv.

[27]  John C. Lin,et al.  Prevalence of Pathogenic and Potentially Pathogenic Inborn Error of Immunity Associated Variants in Children with Severe Sepsis , 2021, Journal of clinical immunology.

[28]  Ariel J. Levine,et al.  Confronting false discoveries in single-cell differential expression , 2021, Nature Communications.

[29]  Yutaka Suzuki,et al.  Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens , 2021, Scientific reports.

[30]  Cameron R. Wolfe,et al.  Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 , 2020, The New England journal of medicine.

[31]  J. Knight,et al.  Host genetics and infectious disease: new tools, insights and translational opportunities , 2020, Nature Reviews Genetics.

[32]  D. Figarella-Branger,et al.  SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution. , 2020, Cell metabolism.

[33]  N. Matsuda,et al.  Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis , 2020, Scientific Reports.

[34]  Douglas R. McDonald,et al.  Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1 , 2020, Journal of Allergy and Clinical Immunology.

[35]  J. Schuurs-Hoeijmakers,et al.  Presence of Genetic Variants Among Young Men With Severe COVID-19. , 2020, JAMA.

[36]  Yufeng Hu,et al.  Phospho-Tyr705 of STAT3 is a therapeutic target for sepsis through regulating inflammation and coagulation , 2020, Cell Communication and Signaling.

[37]  F. Meziani,et al.  JAK-STAT Targeting Offers Novel Therapeutic Opportunities in Sepsis. , 2020, Trends in molecular medicine.

[38]  E. Latz,et al.  STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression , 2020, Nature Communications.

[39]  Ranjit S. Chima,et al.  Trajectories and Risk Factors for Altered Physical and Psychosocial Health-Related Quality of Life After Pediatric Community-Acquired Septic Shock* , 2020, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[40]  A. Nishisaki,et al.  Risk of Mortality in Immunocompromised Children With Severe Sepsis and Septic Shock , 2020, Critical care medicine.

[41]  Amber Dance What is a cytokine storm? , 2020 .

[42]  L. Coin,et al.  Whole-exome Sequencing for the Identification of Rare Variants in Primary Immunodeficiency Genes in Children With Sepsis: A Prospective, Population-based Cohort Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  Ranjit S. Chima,et al.  Critical Illness Factors Associated With Long-Term Mortality and Health-Related Quality of Life Morbidity Following Community-Acquired Pediatric Septic Shock* , 2020, Critical care medicine.

[44]  C. Deutschman,et al.  MITOCHONDRIAL DYSFUNCTION IS ASSOCIATED WITH AN IMMUNE PARALYSIS PHENOTYPE IN PEDIATRIC SEPSIS. , 2019, Shock.

[45]  C. Lindsell,et al.  Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model , 2019, Science Translational Medicine.

[46]  C. Deutschman,et al.  Persistent Mitochondrial Dysfunction Linked to Prolonged Organ Dysfunction in Pediatric Sepsis. , 2019, Critical care medicine.

[47]  E. K. Shriver,et al.  A Multicenter Network Assessment of Three Inflammation Phenotypes in Pediatric Sepsis-Induced Multiple Organ Failure. , 2019, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[48]  J. Casanova,et al.  Severe influenza pneumonitis in children with inherited TLR3 deficiency , 2019, The Journal of experimental medicine.

[49]  Jeremy C. Weiss,et al.  Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. , 2019, JAMA.

[50]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..

[51]  S. Elledge,et al.  Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency , 2018, The Journal of experimental medicine.

[52]  Michael Barnes,et al.  M3C: Monte Carlo reference-based consensus clustering , 2018, Scientific Reports.

[53]  Purvesh Khatri,et al.  Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters , 2018, Critical care medicine.

[54]  Purvesh Khatri,et al.  A community approach to mortality prediction in sepsis via gene expression analysis , 2018, Nature Communications.

[55]  Peter Nürnberg,et al.  Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.

[56]  V. Nadkarni,et al.  The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die* , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[57]  Paul J. Rathouz,et al.  Regularized Ordinal Regression and the ordinalNet R Package , 2017, J. Stat. Softw..

[58]  P. Jouvet,et al.  Modalities and Complications Associated With the Use of High-Flow Nasal Cannula: Experience in a Pediatric ICU , 2016, Respiratory Care.

[59]  J. Fellay,et al.  Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired Pseudomonas aeruginosa Sepsis , 2016, Front. Immunol..

[60]  Hao Chen,et al.  Cytofkit: A Bioconductor Package for an Integrated Mass Cytometry Data Analysis Pipeline , 2016, PLoS Comput. Biol..

[61]  Hao Chen,et al.  flowAI: automatic and interactive anomaly discerning tools for flow cytometry data , 2016, Bioinform..

[62]  J. Knight,et al.  Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study , 2016, The Lancet. Respiratory medicine.

[63]  J. Casanova Severe infectious diseases of childhood as monogenic inborn errors of immunity , 2015, Proceedings of the National Academy of Sciences.

[64]  Y. Saeys,et al.  FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[65]  Purvesh Khatri,et al.  A comprehensive time-course–based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set , 2015, Science Translational Medicine.

[66]  D. Chaussabel,et al.  Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency , 2015, Science.

[67]  C. Lindsell,et al.  Developing a clinically feasible personalized medicine approach to pediatric septic shock. , 2015, American journal of respiratory and critical care medicine.

[68]  V. Nadkarni,et al.  Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells in Pediatric Septic Shock* , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[69]  G. Besner,et al.  Innate Immune Function Predicts the Development of Nosocomial Infection in Critically Injured Children , 2014, Shock.

[70]  M. Hall,et al.  Early adaptive immune suppression in children with septic shock: a prospective observational study , 2014, Critical Care.

[71]  J. Marshall,et al.  Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.

[72]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[73]  Bruno Grandbastien,et al.  PELOD-2: An Update of the PEdiatric Logistic Organ Dysfunction Score , 2013, Critical care medicine.

[74]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[75]  A. Randolph,et al.  Innate Immune Function and Mortality in Critically Ill Children With Influenza: A Multicenter Study* , 2013, Critical care medicine.

[76]  E. Steyerberg,et al.  Extending the c‐statistic to nominal polytomous outcomes: the Polytomous Discrimination Index , 2012, Statistics in medicine.

[77]  J. Carcillo,et al.  Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome , 2011, Intensive Care Medicine.

[78]  H. Wong,et al.  Leukocyte subset-derived genomewide expression profiles in pediatric septic shock* , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[79]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[80]  P. Fawcett,et al.  Function of Mitochondrial Stat3 in Cellular Respiration , 2009, Science.

[81]  J. Ritz,et al.  IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. , 2006, Blood.

[82]  H. Zou,et al.  Addendum: Regularization and variable selection via the elastic net , 2005 .

[83]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[84]  S. Sebti,et al.  Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. , 2005, Cancer research.

[85]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[86]  Alain Martinot,et al.  Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study , 2003, The Lancet.

[87]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[88]  J. Carcillo,et al.  Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[89]  John C. Lin,et al.  New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality. , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[90]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[91]  J. Zimmerman,et al.  Pediatric Multiple Organ Dysfunction Syndrome , 2006 .

[92]  M. Mathru Accelerated Lymphocyte Death in Sepsis Occurs by Both the Death Receptor and Mitochondrial PathwaysHotchkiss RS, Osmon SB, Chang KC, et al (Washington Univ, St Louis) J Immunol 174:5110–5118, 2005§ , 2006 .

[93]  Hua Yu,et al.  Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.